TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Visual analog Scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Dopamine Transporters Occupancy in the Basal Ganglia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cardiovascular changes - heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular changes - blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of Continuous Glucose Monitoring (CGM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comparative experience of Oral Glucose Tolerance Test (OGTT) and CGM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SALT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient's satisfaction level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity and specificity of LungLB test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T1rho dispersion signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indices of endocannabinoid signaling system (ECSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negativation of the RT-PCR test on nasopharyngeal samples of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: intraoperative BIS variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global longitudinal strain (GLS, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body Image Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vaccine Effectiveness (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of newborns with heterozygous mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Exercise Therapy Approach- Biopsychosocial Questionnaire (CETA-BQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Knowledge of Genetic Screening for Breast Cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change intention to be screened and to gather family history and share with providers
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes of International Cooperative Ataxia Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of SARA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent cardiovascular event rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % of patients with pocket closure at worst site per mouth for intrabony defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in NPRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Step Counts at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Physical Activity Level at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pre-operative BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systemic anti-influenza antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mucosal anti-influenza antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of signal coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SLE Responder Index (SRI) 4 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative Interview
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Engagement with the CT-MICART app
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: DNA Damage markers in granulosa cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of Participants Achieving DAS28 CRP Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of nerve localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with no documented recurrence of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to remove the external feeding device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidences of treatment-emergent adverse events (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Vertical foot clearance, lead limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstacle crossing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Saving Inventory-Revised (SI-R)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Self-report Clutter Image Rating (CIR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of oral ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Activity (Beta Power) in Left vLPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain Activity (Beta Power) in Right vLPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain Activity (Beta Power) in Left dlPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain Activity (Beta Power) in Right dlPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional Connectivity Between Left and Right vLPFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: System Usability Scale (Q5 and Q10)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative variation of aberrant methylated ctDNA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between patients' recurrence or progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between survival outcomes (progression free survival, overall survival)
Endpoint domain: Mortality/survival
Primary endpoint: Headache impact test 6 (HIT-6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-Concussion Symptom Scale (PCSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reinitiation of late antiretroviral therapy (ART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight changes after tonsillectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skeletal muscle mass changes after tonsillectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body Fat Mass changes after tonsillectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: falls rate
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Corneal Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best-Corrected Distance Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute graft versus host disease (aGVHD) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-related delays in start of standard of care therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: transfusion dependency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Erythroid Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Facial Inflammatory Lesion Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Burnout measured by emotional exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Burnout measured by Interpersonal Disengagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participant approval
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acute Respiratory Distress Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lumbar Spine Flexion Active Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lumbar Spine Extension Active Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lumbar Spine Right Side Bending Active Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lumbar Spine Left Side Bending Active Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lumbar Spine Right Axial Rotation Active Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Study retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of months needed for completion of trial enrollment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of the study: survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Invasive Disease Free Survival at 3 Years
Endpoint domain: Mortality/survival
Primary endpoint: VWM dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of positive or negative symptoms of schizophrenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSA Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nausea and/or vomiting score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of delayed gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Persistent pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attention and Impulsivity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prosocial Behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Wound Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of Personality Disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from discharge to first non-adherence event
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean change in 28-Joint Disease Activity Score (DAS28-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 2-hr MMTT AUC C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient-Reported Outcome Measurement Information System (PROMIS) 10-item short form
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Integrity of interlobar fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean clinical recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No major adverse events within 30 days after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of entry tears closure 6 months after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of casdatifan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Time Curve From Hour 0 to the Last Sample With Measurable Plasma Concentrations (AUClast) of casdatifan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itch assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: FoxO3a and PU.1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients tolerating RESP301 at each dose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insulin-like growth factor 1 (IGF-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in growth hormone level (GH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in acromegaly related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occlusal outcomes assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arch parameter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute error of predicted CBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bias of predicted CBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard deviation of predicted CBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SpO2-oscillations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of the vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with an Early Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in neuropsychiatric symptoms as assessed by Neuropsychiatric Inventory (NPI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in quality of life as assessed by the Quality of life in Alzheimer's Disease (QOL-AD) tool
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in subjective caregiver burden as assessed by the Zarit Burden Inventory-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Percentage change in plasma sVCAM1, e-selectin, GDF-15 and NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage change in total pulmonary resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency and severity of toxicities related to dapagliflozin
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients completing at least 80% of planned dapagliflozin doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reaction time on language task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on language task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tau PET scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of re-hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Blood glucose control of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Medication adherence of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Root coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in serum concentration of inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in serum concentration of Nuclear factor kB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in serum concentration of oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness for treatment study inclusion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient adherence
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Patient satisfaction with therapy intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seroconversion at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adherence to blood pressure monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sex Practices
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Negotiating Self-Efficacy for Safer Sex
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Means of systolic blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response to treatment with Lutathera®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of treatment with CNA3103
Endpoint domain: Adverse events/effects
Primary endpoint: Overall best response to CNA3103
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of care NPSS
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in quality of care through the patients eyes
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Quality of care (GS-PEQ)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Quality of care (Picker)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Proportion of participants achieving a genital Vitiligo Noticeable Score (VNS) of 4 or 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: complete response rate (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of PRISM Intervention Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of Study Assessment Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of adverse events (AEs)/ serious adverse event (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain in the perineal space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications of healing of birth trauma
Endpoint domain: Adverse events/effects
Primary endpoint: Pain in the perineum in relation to bodily and motor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinitis symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nasal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentration of antibody against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PrEP persistence at 7 months after PrEP initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP adherence at 7 months after PrEP initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from CD-TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Monthly Migraine Days (MMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly Headache Days (MHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COVID-19 booster vaccination rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in likelihood of recommending COVID-19 vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decay teeth, Missed teeth and filled teeth (DMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Acceptability of SMART-HABITS-4-Health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 7-day point prevalence abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in plasma levels of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma levels of glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma levels of insulin/C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in brown adipose tissue activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes